CD8A and prostate carcinoma: A previous study also demonstrated non-functional CD8+ T cells in mice with prostate cancer, using a double transgenic model, which regained function after removal from the tumor-bearing mice, indicating a prostate-cancer specific phenomenon that leads to CD8+ T-cell inactivation [30].